Literature DB >> 23011115

In Zucker diabetic fatty rats, subclinical diabetic neuropathy increases in vivo lidocaine block duration but not in vitro neurotoxicity.

Philipp Lirk1, Magdalena Flatz, Ingrid Haller, Barbara Hausott, Stephan Blumenthal, Markus F Stevens, Suzuko Suzuki, Lars Klimaschewski, Peter Gerner.   

Abstract

BACKGROUND AND OBJECTIVES: Application of local anesthetics may lead to nerve damage. Increasing evidence suggests that risk of neurotoxicity is higher in patients with diabetic peripheral neuropathy. In addition, block duration may be prolonged in neuropathy. We sought to investigate neurotoxicity in vitro and block duration in vivo in a genetic animal model of diabetes mellitus type 2.
METHODS: In the first experiments, neurons harvested from control Zucker diabetic fatty (ZDF) rats were exposed to acute (24 hours) or chronic (72 hours) hyperglycemia, followed by incubation with lidocaine 40 mM (approximately 1%). In a second experiment, neurons harvested from control ZDF rats, or diabetic ZDF rats, were incubated with lidocaine, with or without SB203580, an inhibitor of the p38 mitogen-activated protein kinase. Finally, we performed sciatic nerve block (lidocaine 2%, 0.2 mL) in control or diabetic ZDF rats and measured motor and nociceptive block duration.
RESULTS: In vitro, neither acute nor chronic hyperglycemia altered neurotoxic properties of lidocaine. In vitro, incubation of neurons with lidocaine resulted in a slightly decreased survival ratio when neurons were harvested from diabetic (57% ± 19%) as compared with control (64% ± 9%) rats. The addition of SB203580 partly reversed this enhanced neurotoxic effect and raised survival to 71% ± 12% in diabetic neurons and 66% ± 9% in control rats, respectively. In vivo, even though no difference was detected at baseline testing, motor block was significantly prolonged in diabetic as compared with control rats (137 ± 16 vs 86 ± 17 min).
CONCLUSIONS: In vitro, local anesthetic neurotoxicity was more pronounced on neurons from diabetic animals, but the survival difference was small. In vivo, subclinical neuropathy leads to substantial prolongation of block duration. We conclude that early diabetic neuropathy increases block duration, whereas the observed increase in toxicity was small.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23011115      PMCID: PMC3480545          DOI: 10.1097/AAP.0b013e3182664afb

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  33 in total

1.  Diffuse brachial plexopathy after interscalene blockade in a patient receiving cisplatin chemotherapy: the pharmacologic double crush syndrome.

Authors:  J R Hebl; T T Horlocker; D J Pritchard
Journal:  Anesth Analg       Date:  2001-01       Impact factor: 5.108

2.  [Peripheral nerve block: yesterday's facts and tomorrow's challenges].

Authors:  Y Auroy; D Benhamou; H Bouaziz; C Ecoffey; F J Mercier; P Narchi; K Samii
Journal:  Ann Fr Anesth Reanim       Date:  2005-10-25

3.  Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro.

Authors:  S Horstmann; P J Kahle; G D Borasio
Journal:  J Neurosci Res       Date:  1998-05-15       Impact factor: 4.164

4.  Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats.

Authors:  Christine L Oltman; Lawrence J Coppey; Jill S Gellett; Eric P Davidson; Donald D Lund; Mark A Yorek
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-02-22       Impact factor: 4.310

5.  Diabetes increases sciatic nerve susceptibility to endothelin-induced ischemia.

Authors:  D W Zochodne; C Cheng; H Sun
Journal:  Diabetes       Date:  1996-05       Impact factor: 9.461

6.  Differential neurotoxicity of tricyclic antidepressants and novel derivatives in vitro in a dorsal root ganglion cell culture model.

Authors:  I Haller; P Lirk; C Keller; G K Wang; P Gerner; L Klimaschewski
Journal:  Eur J Anaesthesiol       Date:  2007-04-17       Impact factor: 4.330

7.  Local anesthetic sciatic nerve block and nerve fiber damage in diabetic rats.

Authors:  Jeffrey S Kroin; Asokumar Buvanendran; Dana K Williams; Brian Wagenaar; Mario Moric; Kenneth J Tuman; James M Kerns
Journal:  Reg Anesth Pain Med       Date:  2010 Jul-Aug       Impact factor: 6.288

8.  Neurologic evaluation of the rat during sciatic nerve block with lidocaine.

Authors:  J G Thalhammer; M Vladimirova; B Bershadsky; G R Strichartz
Journal:  Anesthesiology       Date:  1995-04       Impact factor: 7.892

9.  In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity.

Authors:  Philipp Lirk; Ingrid Haller; Hans Peter Colvin; Leopold Lang; Bettina Tomaselli; Lars Klimaschewski; Peter Gerner
Journal:  Anesth Analg       Date:  2008-05       Impact factor: 5.108

10.  Assessment of differential blockade by amitriptyline and its N-methyl derivative in different species by different routes.

Authors:  Peter Gerner; Anna E Haderer; Mustafa Mujtaba; Yukari Sudoh; Sanjeet Narang; Salahadin Abdi; Venkatesh Srinivasa; Christof Pertl; Ging Kuo Wang
Journal:  Anesthesiology       Date:  2003-06       Impact factor: 7.892

View more
  9 in total

1.  KLF9 regulates PRDX6 expression in hyperglycemia-aggravated bupivacaine neurotoxicity.

Authors:  Hui Li; Yaqian Weng; Luying Lai; Hongyi Lei; Shiyuan Xu; Yang Zhang; Le Li
Journal:  Mol Cell Biochem       Date:  2021-02-05       Impact factor: 3.396

2.  Possible utility of contrast-enhanced ultrasonography for detecting spread of local anesthetic in nerve block.

Authors:  Hideaki Sasaki; Masanori Yamauchi; Takafumi Ninomiya; Haruyuki Tatsumi; Michiaki Yamakage
Journal:  J Anesth       Date:  2017-04-03       Impact factor: 2.078

3.  Presentation of Neurolytic Effect of 10% Lidocaine after Perineural Ultrasound Guided Injection of a Canine Sciatic Nerve: A Pilot Study.

Authors:  David D Kim; Asma Asif; Sandeep Kataria
Journal:  Korean J Pain       Date:  2016-07-01

Review 4.  Alternatives to the Streptozotocin-Diabetic Rodent.

Authors:  M A Yorek
Journal:  Int Rev Neurobiol       Date:  2016-03-28       Impact factor: 3.230

5.  Insulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid Emulsion.

Authors:  Michael R Fettiplace; Katarzyna Kowal; Richard Ripper; Alexandria Young; Kinga Lis; Israel Rubinstein; Marcelo Bonini; Richard Minshall; Guy Weinberg
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

6.  Effects of hyperbaric factors on lidocaine-induced apoptosis in spinal neurons and the role of p38 mitogen-activated protein kinase in rats with diabetic neuropathic pain.

Authors:  Xiaolan Zheng; Ling Chen; Xiaohong Du; Junying Cai; Shuchun Yu; Hongtao Wang; Guohai Xu; Zhenzhong Luo
Journal:  Exp Ther Med       Date:  2017-04-13       Impact factor: 2.447

7.  Prolongation of greater occipital neural blockade with 10% lidocaine neurolysis: a case series of a new technique.

Authors:  David Daewhan Kim; Nabil Sibai
Journal:  J Pain Res       Date:  2016-09-29       Impact factor: 3.133

8.  Neurotoxicity of bupivacaine and liposome bupivacaine after sciatic nerve block in healthy and streptozotocin-induced diabetic mice.

Authors:  Liljana Markova; Nejc Umek; Simon Horvat; Admir Hadžić; Max Kuroda; Tatjana Stopar Pintarič; Vesna Mrak; Erika Cvetko
Journal:  BMC Vet Res       Date:  2020-07-17       Impact factor: 2.741

9.  Retrospective Analysis of 0.25% Bupivacaine for Ultrasound-Guided Infraclavicular and Supraclavicular Nerve Blocks in an Ambulatory Surgery Center.

Authors:  Benjamin Rachman; Alec Bigness; Rahul Mhaskar; Nathan Rachman
Journal:  Cureus       Date:  2022-07-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.